The DOI matches its Crossref record; 266 of the 266 references it cites were found in a registry or an index.
Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Open accessAbstract
SUMMARY: The global incidence of drug-resistant Gram-negative bacillary infections has been increasing, and there is a dire need to develop novel strategies to overcome this problem. Intrinsic resistance in Gram-negative bacteria, such as their protective outer membrane and constitutively overexpressed efflux pumps, is a major survival weapon that renders them refractory to current antibiotics. Several potential avenues to overcome this problem have been at the heart of antibiotic drug discovery in the past few decades. We review some of these strategies, with emphasis on antibiotic hybrids either as stand-alone antibacterial agents or as adjuvants that potentiate a primary antibiotic in Gram-negative bacteria. Antibiotic hybrid is defined in this review as a synthetic construct of two or more pharmacophores belonging to an established agent known to elicit a desired antimicrobial effect. The concepts, advances, and challenges of antibiotic hybrids are elaborated in this article. Moreover, we discuss several antibiotic hybrids that were or are in clinical evaluation. Mechanistic insights into how tobramycin-based antibiotic hybrids are able to potentiate legacy antibiotics in multidrug-resistant Gram-negative bacilli are also highlighted. Antibiotic hybrids indeed have a promising future as a therapeutic strategy to overcome drug resistance in Gram-negative pathogens and/or expand the usefulness of our current antibiotic arsenal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316 · cited 1×
“as a consequence of its structural conformation (39, 43).”
BackgroundExtended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Antimicrobial activity of flavonoids
Cushnie, T. P. T., & Lamb, A. J. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.09.002 · Cited by 3,195
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Quorum sensing signal-response systems in Gram-negative bacteria
Papenfort, K., & Bassler, B. L. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.89 · Cited by 2,256
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,162
Brown, D. G., & Boström, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01409 · Cited by 1,964
Agents that increase the permeability of the outer membrane
Vaara, M. (1992) · Microbiological Reviews · doi:10.1128/mr.56.3.395-411.1992 · Cited by 1,879 · cited 1×
“Other polycationic agents such as the pentabasic polymyxin analogs that increase OM permeability in Gram-negative bacteria are also relatively toxic (312).”
BackgroundSiderophore-Based Iron Acquisition and Pathogen Control
Miethke, M., & Marahiel, M. A. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00012-07 · Cited by 1,774
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Multidrug Resistance in Bacteria
Nikaido, H. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145923 · Cited by 1,682
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Crystal structures explain functional properties of two E. coli porins
Cowan, S. W., Schirmer, T., Rummel, G., Steiert, M., Ghosh, R., Pauptit, R. A., Jansonius, J. N., & Rosenbusch, J. P. (1992) · Nature · doi:10.1038/358727a0 · Cited by 1,520
Antimicrobial resistance: the example of Staphylococcus aureus
Lowy, F. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18535 · Cited by 1,445
Diversity of antimicrobial peptides and their mechanisms of action
Epand, R. M., & Vogel, H. J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00198-4 · Cited by 1,358
The hierarchy quorum sensing network in Pseudomonas aeruginosa
Lee, J., & Zhang, L. (2015) · Protein & Cell · doi:10.1007/s13238-014-0100-x · Cited by 1,346
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Hancock, R. E. W., & Chapple, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1317 · Cited by 1,190
Aminoglycosides: Activity and Resistance
Mingeot-Leclercq, M.-P., Glupczynski, Y., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.727 · Cited by 1,113
Bacterial Iron Sources: From Siderophores to Hemophores
Wandersman, C., & Delepelaire, P. (2004) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123811 · Cited by 930
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Predictive compound accumulation rules yield a broad-spectrum antibiotic
Richter, M. F., Drown, B. S., Riley, A. P., Garcia, A., Shirai, T., Svec, R. L., & Hergenrother, P. J. (2017) · Nature · doi:10.1038/nature22308 · Cited by 891
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Tsai, C. J.-Y., Loh, J. M. S., & Proft, T. (2016) · Virulence · doi:10.1080/21505594.2015.1135289 · Cited by 778
A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
O’Loughlin, C. T., Miller, L. C., Siryaporn, A., Drescher, K., Semmelhack, M. F., & Bassler, B. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316981110 · Cited by 744
The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses
Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., & Hancock, R. E. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3883 · Cited by 713
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Quorum quenching: role in nature and applied developments
Grandclément, C., Tannières, M., Moréra, S., Dessaux, Y., & Faure, D. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv038 · Cited by 700
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
Mechanism of bactericidal action of aminoglycosides
Davis, B. D. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.3.341-350.1987 · Cited by 620
Lipinski, C. A. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.029 · Cited by 609
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Bacterial uptake of aminoglycoside antibiotics
Taber, H. W., Mueller, J. P., Miller, P. F., & Arrow, A. S. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.4.439-457.1987 · Cited by 598
Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram‐Negative Bacteria
Hancock, R. E. W. (1998) · Clinical Infectious Diseases · doi:10.1086/514909 · Cited by 583
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Zgurskaya, H. I., López, C. A., & Gnanakaran, S. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00097 · Cited by 580
Chemiosmotic coupling in oxidative and photosynthetic phosphorylation
Mitchell, P. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.09.018 · Cited by 573
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
Needham, B. D., & Trent, M. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3047 · Cited by 565 · cited 1×
“differences in drug permeation rates among Gram-negative organisms (27).”
BackgroundALTERATIONS IN OUTER MEMBRANE PERMEABILITY
Hancock, R. E. W. (1984) · Annual Review of Microbiology · doi:10.1146/annurev.mi.38.100184.001321 · Cited by 564
Hilf, M., Yu, V. L., Sharp, J., Zuravleff, J. J., Korvick, J. A., & Muder, R. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90695-5 · Cited by 563
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998) · Pure and Applied Chemistry · doi:10.1351/pac199870051129 · Cited by 529
Bacterial resistance to antibiotics: Active efflux and reduced uptake
KUMAR, A., & SCHWEIZER, H. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.004 · Cited by 529
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Cationic amphiphilic peptides with cancer-selective toxicity
Schweizer, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.043 · Cited by 517
Self-citationResistance to Trimethoprim-Sulfamethoxazole
Eliopoulos, G. M., & Huovinen, P. (2001) · Clinical Infectious Diseases · doi:10.1086/320532 · Cited by 500
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Microbial Persistence and the Road to Drug Resistance
Cohen, N. R., Lobritz, M. A., & Collins, J. J. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.009 · Cited by 460
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Higgins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Structure, function and regulation of Pseudomonas aeruginosa porins
Chevalier, S., Bouffartigues, E., Bodilis, J., Maillot, O., Lesouhaitier, O., Feuilloley, M. G. J., Orange, N., Dufour, A., & Cornelis, P. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux020 · Cited by 423
Aminoglycoside Antibiotics in the 21st Century
Becker, B., & Cooper, M. A. (2013) · ACS Chemical Biology · doi:10.1021/cb3005116 · Cited by 419
Trimethoprim-Sulfamethoxazole Revisited
Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., & Joshi, N. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.402 · Cited by 408
Effect of Divalent Cation Removal on the Structure of Gram-Negative Bacterial Outer Membrane Models
Clifton, L. A., Skoda, M. W. A., Le Brun, A. P., Ciesielski, F., Kuzmenko, I., Holt, S. A., & Lakey, J. H. (2015) · Langmuir · doi:10.1021/la504407v · Cited by 389
Progress and Challenges in Implementing the Research on ESKAPE Pathogens
Rice, L. B. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/655995 · Cited by 370
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
Kipnis, E., Sawa, T., & Wiener-Kronish, J. (2006) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.10.007 · Cited by 353
Ito, A., Nishikawa, T., Matsumoto, S., Yoshizawa, H., Sato, T., Nakamura, R., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-16 · Cited by 352 · cited 2×
“aeruginosa via iron transporters, besides entering through nonselective porin channels, resulting in enhanced intracellular entry (241).”
BackgroundFalagas, M. E., Lourida, P., Poulikakos, P., Rafailidis, P. I., & Tansarli, G. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01222-13 · Cited by 351
Antibiotics in the clinical pipeline at the end of 2015
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.72 · Cited by 349
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Immunomodulatory Activities of Small Host Defense Peptides
Bowdish, D. M. E., Davidson, D. J., Scott, M. G., & Hancock, R. E. W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1727-1732.2005 · Cited by 316
Achieving global targets for antimicrobial resistance
Laxminarayan, R., Sridhar, D., Blaser, M., Wang, M., & Woolhouse, M. (2016) · Science · doi:10.1126/science.aaf9286 · Cited by 315
Multi-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Energy source of flagellar type III secretion
Paul, K., Erhardt, M., Hirano, T., Blair, D. F., & Hughes, K. T. (2008) · Nature · doi:10.1038/nature06497 · Cited by 309
THE PROTON MOTIVE FORCE IN BACTERIA: A CRITICAL ASSESSMENT OF METHODS
Kashket, E. R. (1985) · Annual Review of Microbiology · doi:10.1146/annurev.mi.39.100185.001251 · Cited by 309
Outer Membrane Active Transport: Structure of the BtuB:TonB Complex
Shultis, D. D., Purdy, M. D., Banchs, C. N., & Wiener, M. C. (2006) · Science · doi:10.1126/science.1127694 · Cited by 308
Glycopeptide antibiotics: Back to the future
Butler, M. S., Hansford, K. A., Blaskovich, M. A. T., Halai, R., & Cooper, M. A. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2014.111 · Cited by 303
Antibiotic Resistance in Bacteria and Its Future for Novel Antibiotic Development
YONEYAMA, H., & KATSUMATA, R. (2006) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.70.1060 · Cited by 286
What Antimicrobial Resistance Has Taught Us About Horizontal Gene Transfer
Barlow, M. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-853-9_23 · Cited by 282
Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane
Hancock, R. E., & Wong, P. G. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.26.1.48 · Cited by 282
Farha, M. A., Verschoor, C. P., Bowdish, D., & Brown, E. D. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.07.006 · Cited by 278
Oz, T., Guvenek, A., Yildiz, S., Karaboga, E., Tamer, Y. T., Mumcuyan, N., Ozan, V. B., Senturk, G. H., Cokol, M., Yeh, P., et al. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu191 · Cited by 275
Antibiotics in the clinical pipeline in 2011
Butler, M. S., & Cooper, M. A. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.44 · Cited by 272
Collateral sensitivity of antibiotic-resistant microbes
Pál, C., Papp, B., & Lázár, V. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.02.009 · Cited by 270
Uptake pathways of anionic and cationic photosensitizers into bacteria
George, S., Hamblin, M. R., & Kishen, A. (2009) · Photochemical & Photobiological Sciences · doi:10.1039/b809624d · Cited by 259
The structural biology of β-barrel membrane proteins: a summary of recent reports
Fairman, J. W., Noinaj, N., & Buchanan, S. K. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.05.005 · Cited by 257
Brown, D. G., May-Dracka, T. L., Gagnon, M. M., & Tommasi, R. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501552x · Cited by 253
Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity
Ning, X., Lee, S., Wang, Z., Kim, D., Stubblefield, B., Gilbert, E., & Murthy, N. (2011) · Nature Materials · doi:10.1038/nmat3074 · Cited by 250
Antibiotic adjuvants: multicomponent anti-infective strategies
Kalan, L., & Wright, G. D. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001766 · Cited by 249
Kohira, N., West, J., Ito, A., Ito-Horiyama, T., Nakamura, R., Sato, T., Rittenhouse, S., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01695-15 · Cited by 247
Piggot, T. J., Holdbrook, D. A., & Khalid, S. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp207013v · Cited by 241
Cationic Host Defence Peptides: Multifaceted Role in Immune Modulation and Inflammation
Choi, K.-Y., Chow, L. N. Y., & Mookherjee, N. (2012) · Journal of Innate Immunity · doi:10.1159/000336630 · Cited by 240
Nau, R., & Eiffert, H. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.1.95-110.2002 · Cited by 240
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Zavascki, A. P., & Nation, R. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02319-16 · Cited by 239
Inhibitors of efflux pumps in Gram-negative bacteria
Pagès, J.-M., Masi, M., & Barbe, J. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.06.006 · Cited by 238
Bohnert, J. A., & Kern, W. V. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.849-852.2005 · Cited by 226
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1345 · Cited by 226
Nicas, T. I., & Hancock, R. E. W. (1980) · Journal of Bacteriology · doi:10.1128/jb.143.2.872-878.1980 · Cited by 221
Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia
Chamot, E., Boffi El Amari, E., Rohner, P., & Van Delden, C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2756-2764.2003 · Cited by 218
Small Molecular Antibacterial Peptoid Mimics: The Simpler the Better!
Ghosh, C., Manjunath, G. B., Akkapeddi, P., Yarlagadda, V., Hoque, J., Uppu, D. S. S. M., Konai, M. M., & Haldar, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401680a · Cited by 205
Antibiotic uptake into gram-negative bacteria
Hancock, R. E. W., & Bell, A. (1988) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01975036 · Cited by 201
What is an “ideal” antibiotic? Discovery challenges and path forward
Singh, S. B., Young, K., & Silver, L. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.003 · Cited by 201
White, A. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh050 · Cited by 198
Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects.
Sharma, P. C., Jain, A., & Jain, S. K. (2010) · PubMed · Cited by 196
Evolution of Resistance to Quorum-Sensing Inhibitors
Kalia, V. C., Wood, T. K., & Kumar, P. (2014) · Microbial Ecology · doi:10.1007/s00248-013-0316-y · Cited by 192
Ito, A., Kohira, N., Bouchillon, S. K., West, J., Rittenhouse, S., Sader, H. S., Rhomberg, P. R., Jones, R. N., Yoshizawa, H., Nakamura, R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv402 · Cited by 192
Cephalosporinase and penicillinase activities of a β-lactamase from Pseudomonas pyocyanea
Sabath, L., Jago, M., & Abraham, E. (1965) · Biochemical Journal · doi:10.1042/bj0960739 · Cited by 190
Identification and characterization of porins in Pseudomonas aeruginosa.
Nikaido, H., Nikaido, K., & Harayama, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35239-0 · Cited by 190
Multiresistant Gram-negative infections: a global perspective
Ho, J., Tambyah, P. A., & Paterson, D. L. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833f0d3e · Cited by 189
Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Ito-Horiyama, T., Ishii, Y., Ito, A., Sato, T., Nakamura, R., Fukuhara, N., Tsuji, M., Yamano, Y., Yamaguchi, K., & Tateda, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03098-15 · Cited by 187
Peterson, L. R. (2001) · Clinical Infectious Diseases · doi:10.1086/321846 · Cited by 183
Bacterial Multidrug Efflux Transporters
Delmar, J. A., Su, C.-C., & Yu, E. W. (2014) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022855 · Cited by 183
Lucasti, C., Vasile, L., Sandesc, D., Venskutonis, D., McLeroth, P., Lala, M., Rizk, M. L., Brown, M. L., Losada, M. C., Pedley, A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-16 · Cited by 182
Bifunctional antimicrobial conjugates and hybrid antimicrobials
Klahn, P., & Brönstrup, M. (2017) · Natural Product Reports · doi:10.1039/c7np00006e · Cited by 181
Hancock, R. E., Farmer, S. W., Li, Z. S., & Poole, K. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1309 · Cited by 180
Sobel, M. L., McKay, G. A., & Poole, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3202-3207.2003 · Cited by 179
A Gestalt approach to Gram-negative entry
Silver, L. L. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.06.044 · Cited by 178
Schalk, I. J., Mislin, G. L. A., & Brillet, K. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394390-3.00002-1 · Cited by 175
Kern, W. V., Steinke, P., Schumacher, A., Schuster, S., Baum, H. V., & Bohnert, J. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki445 · Cited by 172
Bambeke, F., Pages, J.-M., & Lee, V. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106777452692 · Cited by 171
Antiinfectives targeting enzymes and the proton motive force
Feng, X., Zhu, W., Schurig-Briccio, L. A., Lindert, S., Shoen, C., Hitchings, R., Li, J., Wang, Y., Baig, N., Zhou, T., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521988112 · Cited by 171
Molecular Dynamics and NMR Spectroscopy Studies of E. coli Lipopolysaccharide Structure and Dynamics
Wu, E. L., Engström, O., Jo, S., Stuhlsatz, D., Yeom, M. S., Klauda, J. B., Widmalm, G., & Im, W. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.08.002 · Cited by 168
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
Blizzard, T. A., Chen, H., Kim, S., Wu, J., Bodner, R., Gude, C., Imbriglio, J., Young, K., Park, Y.-W., Ogawa, A., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.101 · Cited by 168
Pannek, S., Higgins, P. G., Steinke, P., Jonas, D., Akova, M., Bohnert, J. A., Seifert, H., & Kern, W. V. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl081 · Cited by 168
Membrane‐Active Small Molecules: Designs Inspired by Antimicrobial Peptides
Ghosh, C., & Haldar, J. (2015) · ChemMedChem · doi:10.1002/cmdc.201500299 · Cited by 167
Mangoni, M. L., & Shai, Y. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0718-2 · Cited by 159
Considerations and caveats in anti-virulence drug development
Maura, D., Ballok, A. E., & Rahme, L. G. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.06.001 · Cited by 159
Vancomycin, teicoplanin, and ramoplanin: Synthetic and mechanistic studies†
Boger, D. L. (2001) · Medicinal Research Reviews · doi:10.1002/med.1014 · Cited by 156
Antibacterial activity of naringin derivatives against pathogenic strains
Céliz, G., Daz, M., & Audisio, M. C. (2011) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2011.05070.x · Cited by 154
Cheer, S. M., Waugh, J., & Noble, S. (2003) · Drugs · doi:10.2165/00003495-200363220-00015 · Cited by 152
Corbett, D. F., Wise, A., Langley, T., Skinner, K., Trimby, E., Birchall, S., Dorali, A., Sandiford, S. K., Williams, J., Warn, P. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00200-17 · Cited by 148
Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?
Maltezou, H. C. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.09.003 · Cited by 147
Falagas, M. E., Matthaiou, D. K., & Bliziotis, I. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl044 · Cited by 147
Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance
Pokrovskaya, V., & Baasov, T. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.508069 · Cited by 147
Anti-inflammatory therapies in sepsis and septic shock
Freeman, B. D., & Natanson, C. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.7.1651 · Cited by 146
Overcoming differences: The catalytic mechanism of metallo‐β‐lactamases
Meini, M.-R., Llarrull, L. I., & Vila, A. J. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.08.015 · Cited by 145
Antimicrobial action mechanism of flavonoids from Dorstenia species
Dzoyem, J. P., Hamamoto, H., Ngameni, B., Ngadjui, B. T., & Sekimizu, K. (2013) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2013.v7.2.66 · Cited by 145
Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity
Hori, Y., Aoki, N., Kuwahara, S., Hosojima, M., Kaseda, R., Goto, S., Iida, T., De, S., Kabasawa, H., Kaneko, R., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060606 · Cited by 142
Hancock, R. E. W., Decad, G. M., & Nikaido, H. (1979) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(79)90373-0 · Cited by 141
Biochemistry of Bacterial Multidrug Efflux Pumps
Kumar, S. H., & Varela, M. F. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13044484 · Cited by 140
Kriengkauykiat, J., Porter, E. M., Lomovskaya, O., & Wong‐Beringer, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.565-570.2005 · Cited by 137
General Platform for Systematic Quantitative Evaluation of Small-Molecule Permeability in Bacteria
Davis, T. D., Gerry, C. J., & Tan, D. S. (2014) · ACS Chemical Biology · doi:10.1021/cb5003015 · Cited by 134
How many modes of action should an antibiotic have?
Brötz‐Oesterhelt, H., & Brunner, N. A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.008 · Cited by 133
Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’
Khan, S. N., & Khan, A. U. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00174 · Cited by 133
Moynié, L., Lüscher, A., Rolo, D., Pletzer, D., Tortajada, A., Weingart, H., Braun, Y., Page, M. G. P., Naismith, J. H., & Köhler, T. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02531-16 · Cited by 131
Social interactions in bacterial cell–cell signaling
Asfahl, K. L., & Schuster, M. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw038 · Cited by 127
Schumacher, A., Steinke, P., Bohnert, J. A., Akova, M., Jonas, D., & Kern, W. V. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki446 · Cited by 126
Poulikakos, P., Tansarli, G. S., & Falagas, M. E. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2124-9 · Cited by 125
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
The intrinsic resistome ofPseudomonas aeruginosato β-lactams
Alvarez‐Ortega, C., Wiegand, I., Olivares‐Pacheco, J., Hancock, R. E. W., & Martínez, J. L. (2011) · Virulence · doi:10.4161/viru.2.2.15014 · Cited by 123
Arunmanee, W., Pathania, M., Solovyova, A. S., Brun, A. P. L., Ridley, H., Baslé, A., van den Berg, B., & Lakey, J. H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602382113 · Cited by 122
Purification and properties of Pseudomonas aeruginosa porin.
Yoshimura, F., Zalman, L. S., & Nikaido, H. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32924-7 · Cited by 121
Vaara, M., Siikanen, O., Apajalahti, J., Fox, J., Møller, J. K., He, H., Poudyal, A., Li, J., Nation, R. L., & Vaara, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01439-09 · Cited by 119
Aminoglycoside activity observed on single pre-translocation ribosome complexes
Feldman, M. B., Terry, D. S., Altman, R. B., & Blanchard, S. C. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.274 · Cited by 117
Vardakas, K. Z., Tansarli, G. S., Bliziotis, I. A., & Falagas, M. E. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.12.006 · Cited by 115
Katsube, T., ECHOLS, R. M., Ferreira, J. C. A., Krenz, H., Berg, J. K., & Galloway, C. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.841 · Cited by 115
Idowu, T., & Schweizer, F. (2017) · Antibiotics · doi:10.3390/antibiotics6040026 · Cited by 115
Self-citationBera, S., Zhanel, G. G., & Schweizer, F. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800345u · Cited by 113
Self-citationPorins in prokaryotes and eukaryotes: common themes and variations
Zeth, K., & Thein, M. (2010) · Biochemical Journal · doi:10.1042/bj20100371 · Cited by 111
Treatment of Gram-negative bacterial infections by potentiation of antibiotics
Zabawa, T. P., Pucci, M. J., Parr, T. R., & Lister, T. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.005 · Cited by 109
García‐Contreras, R., Martínez‐Vázquez, M., Velázquez‐Guadarrama, N., Pañeda, A. G. V., Hashimoto, T., Maeda, T., Quezada, H., & Wood, T. K. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12039 · Cited by 104
Schumacher, A., Trittler, R., Bohnert, J. A., Kümmerer, K., Pagès, J., & Kern, W. V. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl380 · Cited by 103
Cardoso, T., Ribeiro, O., Aragão, I. C., Costa‐Pereira, A., & Sarmento, A. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-375 · Cited by 102
Monogue, M. L., Tsuji, M., Yamano, Y., ECHOLS, R. M., & Nicolau, D. P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01022-17 · Cited by 101
Effects of Acyl versus Aminoacyl Conjugation on the Properties of Antimicrobial Peptides
Radzishevsky, I. S., Rotem, S., Zaknoon, F., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2412-2420.2005 · Cited by 98
Locher, H. H., Seiler, P. J., Chen, X., Schroeder, S., Pfaff, P., Enderlin, M., Klenk, A., Fournier, E., Hubschwerlen, C., Ritz, D., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01830-13 · Cited by 98
Introduction: historical perspective and development of amoxicillin/clavulanate
Geddes, A. M., Klugman, K. P., & Rolinson, G. N. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.015 · Cited by 96 · cited 1×
“Augmentin was first introduced in 1981 by GlaxoSmithKline and is useful in the clinic even today (124, 125).”
BackgroundZhang, F. Y., Du, G. J., Zhang, L., Zhang, C. L., Lü, W.-L., & Liang, W. P. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9793-y · Cited by 96
Gorityala, B. K., Guchhait, G., Fernando, D. M., Deo, S. R., McKenna, S. A., Zhanel, G. G., Kumar, A., & Schweizer, F. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508330 · Cited by 96
Self-citationNovel approaches for the design and discovery of quorum-sensing inhibitors
Scutera, S., Zucca, M., & Savoia, D. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.894974 · Cited by 94
The Pseudomonas aeruginosa membranes: A target for a new amphiphilic aminoglycoside derivative?
Ouberai, M. M., Garch, F. E., Bussière, A., Riou, M., Alsteens, D., Lins, L., Baussanne, I., Dufrêne, Y. F., Brasseur, R., Décout, J., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.01.014 · Cited by 93
Delta pH-dependent accumulation of tetracycline in Escherichia coli
Yamaguchi, A., Ohmori, H., Kaneko-Ohdera, M., Nomura, T., & Sawai, T. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.53 · Cited by 92
Acetobacter aceti Possesses a Proton Motive Force-Dependent Efflux System for Acetic Acid
Matsushita, K., Inoue, T., Adachi, O., & Toyama, H. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.13.4346-4352.2005 · Cited by 92
Structural basis for substrate specificity in the Escherichia coli maltose transport system
Oldham, M. L., Chen, S., & Chen, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311407110 · Cited by 92
Lyu, Y., Yang, X., Goswami, S., Gorityala, B. K., Idowu, T., Domalaon, R., Zhanel, G. G., Shan, A., & Schweizer, F. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01742 · Cited by 92
Self-citationKatsube, T., Wajima, T., Ishibashi, T., Ferreira, J. C. A., & ECHOLS, R. M. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01381-16 · Cited by 91
Kumar, A., Chua, K.-L., & Schweizer, H. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00440-06 · Cited by 90
Locher, H. H., Caspers, P., Bruyère, T., Schroeder, S., Pfaff, P., Knezevic, A., Keck, W., & Ritz, D. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01831-13 · Cited by 85
Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials
Marcus, R., Paul, M., Elphick, H., & Leibovici, L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.029 · Cited by 84
Xiao, Z., Ma, T., Liao, M.-L., Feng, Y., Peng, X., Li, J., Li, Z., Wu, Y., Luo, Q., Deng, Y., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.047 · Cited by 83
Kim, A., Kutschke, A., Ehmann, D. E., Patey, S. A., Crandon, J. L., Gorseth, E., Miller, A. A., McLaughlin, R. E., Blinn, C. M., Chen, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00831-15 · Cited by 82
Insights into Newer Antimicrobial Agents against Gram-negative Bacteria
Yaneja, N., & Kaur, H. (2016) · Microbiology Insights · doi:10.4137/mbi.s29459 · Cited by 82
A mechanistical model for the uptake of sulfonamides by bacteria
Zarfl, C., Matthies, M., & Klasmeier, J. (2007) · Chemosphere · doi:10.1016/j.chemosphere.2007.07.045 · Cited by 81
Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance
Pieren, M., & Tigges, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.005 · Cited by 81
Karlowsky, J. A., Hoban, D. J., Hackel, M., Lob, S. H., & Sahm, D. F. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000421 · Cited by 80
Herzog, I. M., & Fridman, M. (2014) · MedChemComm · doi:10.1039/c4md00012a · Cited by 79
Molecular Recognition by Glycoside Pseudo Base Pairs and Triples in an Apramycin–RNA Complex
Han, Q., Zhao, Q., Fish, S., Simonsen, K. B., Vourloumis, D., Froelich, J. M., Wall, D., & Hermann, T. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500028 · Cited by 79
Yang, X., Goswami, S., Gorityala, B. K., Domalaon, R., Lyu, Y., Kumar, A., Zhanel, G. G., & Schweizer, F. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00156 · Cited by 79
Self-citationPyrithione biocides as inhibitors of bacterial ATP synthesis
Dinning, Al-Adham, I. S. I., Eastwood, et al. (1998) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.1998.00478.x · Cited by 78
Are natural products still the best source for antibacterial discovery? The bacterial entry factor
Silver, L. L. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.5.487 · Cited by 78
Lidor, O., Al-Quntar, A., Pesci, E. C., & Steinberg, D. (2015) · Scientific Reports · doi:10.1038/srep16569 · Cited by 77
Robertson, G. T., Bonventre, E. J., Doyle, T. B., Du, Q., Duncan, L. R., Morris, T. W., Roche, E. D., Yan, D., & Lynch, A. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01649-07 · Cited by 76
Louie, T., Nord, C. E., Talbot, G. H., Wilcox, M. H., Gerding, D. N., Buitrago, M. I., Kracker, H., Charef, P., & Cornely, O. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00504-15 · Cited by 76
A variety of roles for versatile zinc in metallo-β-lactamases
Karsisiotis, A. I., Damblon, C., & Roberts, G. C. K. (2014) · Metallomics · doi:10.1039/c4mt00066h · Cited by 75
The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
Falagas, M. E., Mavroudis, A. D., & Vardakas, K. Z. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1204911 · Cited by 75
Gorityala, B. K., Guchhait, G., Goswami, S., Fernando, D. M., Kumar, A., Zhanel, G. G., & Schweizer, F. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00867 · Cited by 75
Self-citationZimmermann, L., Das, I., Désiré, J., Sautrey, G., S., V. B. R., Khoury, M. E., Mingeot‐Leclercq, M., & Décout, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00818 · Cited by 74
Zhou, Y., Joubran, C., Miller-Vedam, L. E., Isabella, V. M., Nayar, A. S., Tentarelli, S., & Miller, A. A. (2015) · Analytical Chemistry · doi:10.1021/ac504880r · Cited by 73
Cited by
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
Mulani, M. S., Kamble, E. E., Kumkar, S. N., Tawre, M. S., & Pardesi, K. R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00539 · Cited by 1,644
The global preclinical antibacterial pipeline
Theuretzbacher, U., Outterson, K., Engel, A., & Karlén, A. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0288-0 · Cited by 738
Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era
Wang, J., Dou, X., Song, J., Lyu, Y., Zhu, X., Xu, L., Li, W., & Shan, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21542 · Cited by 547
Zhanel, G. G., Golden, A. R., Zelenitsky, S., Wiebe, K., Lawrence, C. K., Adam, H. J., Idowu, T., Domalaon, R., Schweizer, F., Zhanel, M. A., et al. (2019) · Drugs · doi:10.1007/s40265-019-1055-2 · Cited by 446
Self-citationAntibiotic Adjuvants: Make Antibiotics Great Again!
Douafer, H., Andrieu, V., Phanstiel, O., & Brunel, J. M. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01781 · Cited by 272
Metadata
- Authors
- Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2018-04
- Volume
- 31
- Issue
- 2
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2792453421
- Cited by
- 285
- References
- 266
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.